Suppr超能文献

半胱氨酸、高半胱氨酸和N-乙酰半胱氨酸的汞共轭物在肾小管摄取无机汞所涉及的机制中的参与情况。

Participation of mercuric conjugates of cysteine, homocysteine, and N-acetylcysteine in mechanisms involved in the renal tubular uptake of inorganic mercury.

作者信息

Zalups R K, Barfuss D W

机构信息

Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, Georgia 31207, USA.

出版信息

J Am Soc Nephrol. 1998 Apr;9(4):551-61. doi: 10.1681/ASN.V94551.

Abstract

Mechanisms involved in the renal uptake of inorganic mercury were studied in rats administered a nontoxic 0.5 mumol/kg intravenous dose of inorganic mercury with or without 2.0 mumol/kg cysteine, homocysteine, or N-acetylcysteine. The renal disposition of mercury was studied 1 h after treatment in normal rats and rats that had undergone bilateral ureteral ligation. In addition, the disposition of mercury (including the urinary and fecal excretion of mercury) was evaluated 24 h after treatment. In normal rats, coadministering inorganic mercury plus cysteine or homocysteine caused a significant increase in the renal uptake of mercury 1 h after treatment. The enhanced renal uptake of mercury was due to increased uptake of mercury in the renal outer stripe of the outer medulla and/or renal cortex. Ureteral ligation caused reductions in the renal uptake of mercury in all groups except for the one treated with inorganic mercury plus N-acetylcysteine. Thus, it appears that virtually all of the mercury taken up by the kidneys of the normal rats treated with inorganic mercury plus N-acetylcysteine occurred at the basolateral membrane. Urinary excretory data also support this notion, in that the rate of excretion of inorganic mercury was greatest in the rats treated with inorganic mercury plus N-acetylcysteine. Our data also indicate that uptake of inorganic mercury in the kidneys of rats treated with inorganic mercury plus cysteine occurred equally at both luminal and basolateral membranes. In addition, the renal uptake of mercury in rats treated with inorganic mercury plus homocysteine occurred predominantly at the basolateral membrane with some component of luminal uptake. The findings of the present study confirm that there are at least two distinct mechanisms involved in the renal uptake of inorganic mercury, with one mechanism located on the luminal membrane and the other located on the basolateral membrane. Our findings also show that cysteine and homologs of cysteine, when coadministered with inorganic mercury, greatly influence the magnitude and/or site of uptake of mercuric ions in the kidney.

摘要

在给大鼠静脉注射无毒剂量0.5 μmol/kg无机汞(伴或不伴有2.0 μmol/kg半胱氨酸、同型半胱氨酸或N - 乙酰半胱氨酸)的情况下,研究了肾脏摄取无机汞的机制。在正常大鼠和双侧输尿管结扎的大鼠中,于治疗后1小时研究汞在肾脏的分布情况。此外,在治疗后24小时评估汞的分布情况(包括汞的尿排泄和粪排泄)。在正常大鼠中,无机汞与半胱氨酸或同型半胱氨酸共同给药导致治疗后1小时肾脏对汞的摄取显著增加。肾脏对汞摄取的增强是由于肾外髓质外层条纹和/或肾皮质中汞摄取的增加。输尿管结扎导致除无机汞加N - 乙酰半胱氨酸治疗组外的所有组中肾脏对汞的摄取减少。因此,似乎在用无机汞加N - 乙酰半胱氨酸治疗的正常大鼠肾脏中摄取的几乎所有汞都发生在基底外侧膜。尿排泄数据也支持这一观点,因为在用无机汞加N - 乙酰半胱氨酸治疗的大鼠中无机汞的排泄率最高。我们的数据还表明,在用无机汞加半胱氨酸治疗的大鼠肾脏中,无机汞在管腔膜和基底外侧膜的摄取是相等的。此外,在用无机汞加同型半胱氨酸治疗的大鼠中,肾脏对汞的摄取主要发生在基底外侧膜,有一些管腔摄取成分。本研究结果证实,肾脏摄取无机汞至少涉及两种不同机制,一种机制位于管腔膜,另一种位于基底外侧膜。我们的研究结果还表明,半胱氨酸及其同系物与无机汞共同给药时,会极大地影响肾脏中汞离子摄取的程度和/或部位。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验